Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial

BACKGROUND: Laboratory evidence has shown that cannabinoids might have a neuroprotective action. We investigated whether oral dronabinol (Δ(9)-tetrahydrocannabinol) might slow the course of progressive multiple sclerosis. METHODS: In this multicentre, parallel, randomised, double-blind, placebo-cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Zajicek, John, Ball, Susan, Wright, David, Vickery, Jane, Nunn, Andrew, Miller, David, Cano, Mayam Gomez, McManus, David, Mallik, Sharukh, Hobart, Jeremy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lancet Pub. Group 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744749/
https://www.ncbi.nlm.nih.gov/pubmed/23856559
http://dx.doi.org/10.1016/S1474-4422(13)70159-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744749/
https://www.ncbi.nlm.nih.gov/pubmed/23856559
http://dx.doi.org/10.1016/S1474-4422(13)70159-5

Ejemplares similares